Dr David Dane relayed to Dr Sheila Waiter that viruses might also be found among other transfused individuals because the non-A non-B Hepatitis viruses may be responsible for abnormal livers which were evidently common among people with haemophilia. Read more about Dr David Dane relayed to Dr Sheila Waiter that viruses might also be found among other transfused individuals because the non-A non-B Hepatitis viruses may be responsible for abnormal livers which were evidently common among people with haemophilia.
Dr Vivian Mitchell noted that for at least some haemophilia patients treated with factor concentrates chronic liver disease could be progressive. Read more about Dr Vivian Mitchell noted that for at least some haemophilia patients treated with factor concentrates chronic liver disease could be progressive.
Dr John Craske and Dr Peter Kirk published a report stating that further research was required to assess the incidence of chronic liver disease after non-B Hepatitis. Read more about Dr John Craske and Dr Peter Kirk published a report stating that further research was required to assess the incidence of chronic liver disease after non-B Hepatitis.
Regional transfusion centres highlighted that blood screening did not occur across the board in respect of whole blood until 1972. Read more about Regional transfusion centres highlighted that blood screening did not occur across the board in respect of whole blood until 1972.
Mr Gidden wrote to the secretaries of regional hospital boards to suggest testing donations for the Australia antigen should reduce the incidence of serum hepatitis to avoid suffering and disablement and even death. Read more about Mr Gidden wrote to the secretaries of regional hospital boards to suggest testing donations for the Australia antigen should reduce the incidence of serum hepatitis to avoid suffering and disablement and even death.
The Report of the Advisory Group on Testing for the Presence of Australia (Hepatitis-Associated) Antigen and its Antibody reported that although the hepatitis agent may be less widely found in the UK, the testing of donations for the Australia antigen should reduce the incidence of serum hepatitis to avoid suffering and disablement and death. Read more about The Report of the Advisory Group on Testing for the Presence of Australia (Hepatitis-Associated) Antigen and its Antibody reported that although the hepatitis agent may be less widely found in the UK, the testing of donations for the Australia antigen should reduce the incidence of serum hepatitis to avoid suffering and disablement and death.
Professor Garrott Allen noted that approximately 0.9% of total transfused patients would suffer disability or death due to transfusion hepatitis. Read more about Professor Garrott Allen noted that approximately 0.9% of total transfused patients would suffer disability or death due to transfusion hepatitis.
Professor Garrott Allen returned to the theme in several following publications that transfusions derived from prison and Skid row populations was at least 10 times that from the use of volunteer donors. Read more about Professor Garrott Allen returned to the theme in several following publications that transfusions derived from prison and Skid row populations was at least 10 times that from the use of volunteer donors.
Mirick et al noted that blood from prison and skid row populations was at least 10 times that from volunteer donors. Read more about Mirick et al noted that blood from prison and skid row populations was at least 10 times that from volunteer donors.
Dr George Grady and others wrote that Hepatitis B antigen accounted for around 60% of the cases of post-transfusion hepatitis. Read more about Dr George Grady and others wrote that Hepatitis B antigen accounted for around 60% of the cases of post-transfusion hepatitis.